VB Spine to Feature xvision X2 Headset and Vulcan Spinal System at NASS 2026
VB Spine highlights next-generation augmented reality navigation and spinal fixation technologies ahead of broader commercial launches.
VB Spine highlights next-generation augmented reality navigation and spinal fixation technologies ahead of broader commercial launches.
Company highlights next-generation augmented reality navigation and spinal fixation technologies ahead of broader commercial launches NEW YORK, October…
VB Spine LLC today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ScolimiR-3D.
Veteran medtech finance executive brings more than two decades of spine and M&A leadership experience
Veteran medtech finance executive brings more than two decades of spine and M&A leadership experience. NEW YORK, October…
ScolimiR-3D, a novel microRNA-based blood test, is designed to enable earlier intervention and personalized management of adolescent idiopathic…
Premia Spine announces today that the American Medical Association's CPT® Editorial Panel has voted to establish a Category I CPT® Code for Posterior Vertebral Column Arthroplasty....
In older patients who sustain a traumatic cervical spinal cord injury (SCI), the absence of a fracture or dislocation can be deceptively reassuring. The CT scan may show an apparen...
RESTON, Va., Oct. 7, 2026 /PRNewswire/ — VSI Spine Solutions (formerly Virginia Spine Institute) announced that orthopedic spine surgeon Alexander Upfill-Brown, MD, MSc, has…
Vy Spine announced today that it has received U.S. Food and Drug Administration (FDA) clearance for its VySion-P SI Fusion and VyStop SI Screw Systems.
Bountiful, UT – November 17, 2026, /OrthoSpineNews/ – Vy Spine, a spine innovation leader using differentiated materials and…
Published by Onrec 19 Oct 2026|Employee Experience & WellbeingHow advanced motion-preserving spine care is reshaping employee return-to-work plansModern motion-preserving spina...
For L4-5 LLIF, is lumbar plexus’s position the #1 cause of postop motor deficits?
Vivex matched 1,804 Medicare patients treated with VIA Disc NP against 1,804 managed with conservative care. Opioid supply, imaging, injections, and physical therapy all dropped in...
rhBMP2 use in ACDF soared 667% in the five years between 2017 – 2022.
Naitive Technologies today announced that it has received FDA 510(k) for OsteoSight Spine.
SurGenTec today announced that it has entered into an exclusive license agreement with Allevion Medical for its patented Vantageâ„¢ spinal decompression technology.
Is carbon fiber the future of spinal tumor reconstruction?
Neurosurgeon Joel Beckett, MD, to discuss how the Synergy Disc’s lordotic core supports alignment alongside motion preservation LOUISVILLE,…
BOURDEAUX, France and NEW YORK and LEESBURG, Va., Oct. 28, 2026 /PRNewswire/ — Companion Spine, the French-American specialist in surgeon-innovated…
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.